The Nutshell

» cancer and funding

Daily News Roundup

Most Recent

image: Science Exchange Raises $25M

Science Exchange Raises $25M

By | March 24, 2016

With fresh funding, the experiment-services and independent-validation startup will expand its staff.

0 Comments

image: TS Picks: March 16, 2016

TS Picks: March 16, 2016

By | March 16, 2016

Corrections give belated credit for immunotherapy; mosquitoes have been bugging us long before Zika; the bright side of irreproducibility 

0 Comments

image: Week in Review: February 22–26

Week in Review: February 22–26

By | February 26, 2016

Questions about how E. coli evolves; spermatids in a dish; fighting bacteria with virus-like molecule; what drives metastasis; antibodies fight Ebola in monkeys

0 Comments

image: Author Nets Seven Retractions

Author Nets Seven Retractions

By | February 22, 2016

Biochemical Pharmacology pulls papers coauthored by a scientist whose work has been under investigation at MD Anderson Cancer Center.

0 Comments

image: NIH Grant Reviews Don’t Predict Success

NIH Grant Reviews Don’t Predict Success

By | February 18, 2016

Peer reviewers’ assessments of funding proposals to the National Institutes of Health don’t correlate well with later publication citations, a study shows.

1 Comment

image: Cancer Detected in Naked Mole Rats

Cancer Detected in Naked Mole Rats

By | February 8, 2016

Two captive males of the cancer-resistant species have shown signs of malignant tumors.

0 Comments

image: Illuminating a Cancer’s Origins

Illuminating a Cancer’s Origins

By | February 1, 2016

Researchers have developed a technique to visualize the origin of melanoma in zebrafish, throwing light on a genetic switch for cancer.

0 Comments

image: Funding Ban for Plant Biologist

Funding Ban for Plant Biologist

By | January 26, 2016

Olivier Voinnet, who has corrected and retracted several papers, cannot receive Swiss government grants for three years.

1 Comment

image: Cancer Not Just “Bad Luck”

Cancer Not Just “Bad Luck”

By | December 18, 2015

A new study refutes one published earlier this year that claimed random mutations were at the root of many tumors.

1 Comment

image: Eminent Cancer Researcher Dies

Eminent Cancer Researcher Dies

By | December 16, 2015

Indiana University’s David Flockhart, a pioneer of personalized medicine, has passed away at age 63. 

0 Comments

Popular Now

  1. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  2. Does Productivity Diminish Research Quality?
  3. How Plants Evolved Different Ways to Make Caffeine
  4. ESP on Trial
    Foundations ESP on Trial

    In the 1930s, parapsychologist Joseph Banks Rhine aimed to use scientific methods to confirm the existence of extrasensory perception, but faced criticisms of dubious analyses and irreproducible results.

RayBiotech